GlaxoSmithKline (GSK) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







Top 5 Coins for the Maximum Passive Income from Staking by 2024

February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024

Staking is one of the ways that is now being used as a secure and profitable way to earn money without doing anything…
Trading Stocks With AI: A Modern Approach

January 21, 2025 Trading Stocks With AI: A Modern Approach

The stock market can feel overwhelming, especially with its constant ups and downs. Trading stocks with AI is revolutionizing how investors analyze trends,…
Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025

January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025

The launch of spot Bitcoin (CRYPTO: BTC) exchange-traded funds (ETFs) in January 2025 marked a turning point in the cryptocurrency market. These ETFs…
Advanced Charting Tools For Traders

January 1, 2025 Advanced Charting Tools For Traders

Ever tried deciphering market trends with the intensity of a detective peering over cryptic clues? Enter the realm of Advanced Charting, where complex…
Why Is Trading Important?

December 21, 2024 Why Is Trading Important?

Trade isn’t just figures on a spreadsheet; it’s the pulse of our global community. In 2018, the United States faced a staggering $621…

GlaxoSmithKline (GSK) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: February 14, 2025 (12:42)

Sector: Healthcare

The share price of GlaxoSmithKline plc (GSK) now

Latest session on the 13th of February for
GlaxoSmithKline plc is positive
Trading Volume: 4462616
Open: 36.17 /  High: 36.62 /  Low: 36.005
Current value: $36.55
What analysts predict: $44.48
52-week High/Low: $44.85 / $31.72
50-Day Moving Average: $34.24 — support level today
200-Day Moving Average: $38.92 — resistance level today

Are you interested in GlaxoSmithKline plc stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the GlaxoSmithKline stock price in 2025, 2026, 2027. How much will one GlaxoSmithKline share be worth in 2025 - 2027?

When should I take profit in GlaxoSmithKline stock? When should I record a loss on GlaxoSmithKline stock? What are analysts' forecasts for GlaxoSmithKline stock? What is the future of GlaxoSmithKline stock? We forecast GlaxoSmithKline stock performance using neural networks based on historical data on GlaxoSmithKline stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

GlaxoSmithKline stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for GlaxoSmithKline shares. This happens once a day.


Historical and forecast chart of GlaxoSmithKline stock

The chart below shows the historical price of GlaxoSmithKline stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the GlaxoSmithKline stock price can be found in the table below.

Long-term forecasts by years.

GlaxoSmithKline plc is engaged in the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines, OTC drugs and health-related consumer products in the United Kingdom, the United States and internationally. It operates in four segments: pharmaceuticals, pharmaceutical research and development, vaccines and consumer healthcare. The company offers pharmaceutical products that include drugs in therapeutic areas such as respiratory, HIV, immunoinflammatory, cancer, antiviral, central nervous system, cardiovascular and urogenital, metabolic, antibacterial and dermatological. It also provides consumer healthcare products in the categories of health, oral health, nutrition, and skin health. The company offers its consumers medical products in the form of nasal sprays, tablets, syrups, lozenges, chewing gums and transdermal patches, drops, drops of baby syrup, liquid suspension, wipes, gels, effervescent substances, toothpastes, toothbrushes, mouth rinses, adhesives for dentures and detergents, topical creams and non-drug plasters, lip balms, chewing gums and soft chewing gums. She has cooperation agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics specializing in immunology. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, UK.

Trending Themes in the Healthcare Sector

GlaxoSmithKline daily forecast for a month

Date Target Pes. Opt. Vol., %
Feb 16 36.38 36.21 36.60 1.07
Feb 17 36.41 36.29 36.67 1.03
Feb 18 36.46 36.28 36.55 0.75
Feb 19 36.56 36.45 36.85 1.09
Feb 20 36.91 36.68 37.17 1.35
Feb 21 37.09 36.99 37.30 0.83
Feb 22 37.02 36.90 37.10 0.55
Feb 23 36.89 36.81 37.13 0.86
Feb 24 36.72 36.50 36.96 1.25
Feb 25 36.77 36.58 37.02 1.19
Feb 26 36.73 36.49 36.85 0.99
Feb 27 36.62 36.42 36.72 0.82
Feb 28 36.88 36.75 37.10 0.93
Mar 01 36.95 36.67 37.11 1.22
Mar 02 37.10 36.91 37.39 1.30
Mar 03 37.19 37.00 37.45 1.21
Mar 04 37.24 37.06 37.53 1.25
Mar 05 37.15 36.96 37.43 1.26
Mar 06 37.11 36.96 37.40 1.20
Mar 07 36.86 36.75 37.14 1.06
Mar 08 37.03 36.91 37.16 0.67
Mar 09 36.78 36.57 37.05 1.31
Mar 10 36.75 36.66 36.91 0.70
Mar 11 37.01 36.73 37.16 1.18
Mar 12 37.11 37.04 37.24 0.55
Mar 13 36.94 36.71 37.06 0.95
Mar 14 36.64 36.53 36.84 0.85
Mar 15 36.66 36.55 36.93 1.03
Mar 16 36.49 36.29 36.73 1.20
Mar 17 36.15 35.86 36.39 1.46

GlaxoSmithKline Daily Price Targets


GlaxoSmithKline Stock Forecast 02-16-2025.

Forecast target price for 02-16-2025: $36.38.
Negative dynamics for GlaxoSmithKline shares will prevail with possible volatility of 1.063%.
Pessimistic target level: 36.21
Optimistic target level: 36.60

GlaxoSmithKline Stock Forecast 02-17-2025.

Forecast target price for 02-17-2025: $36.41.
Positive dynamics for GlaxoSmithKline shares will prevail with possible volatility of 1.023%.
Pessimistic target level: 36.29
Optimistic target level: 36.67

GlaxoSmithKline Stock Forecast 02-18-2025.

Forecast target price for 02-18-2025: $36.46.
Positive dynamics for GlaxoSmithKline shares will prevail with possible volatility of 0.748%.
Pessimistic target level: 36.28
Optimistic target level: 36.55

GlaxoSmithKline Stock Forecast 02-19-2025.

Forecast target price for 02-19-2025: $36.56.
Positive dynamics for GlaxoSmithKline shares will prevail with possible volatility of 1.082%.
Pessimistic target level: 36.45
Optimistic target level: 36.85

GlaxoSmithKline Stock Forecast 02-20-2025.

Forecast target price for 02-20-2025: $36.91.
Positive dynamics for GlaxoSmithKline shares will prevail with possible volatility of 1.331%.
Pessimistic target level: 36.68
Optimistic target level: 37.17

GlaxoSmithKline Stock Forecast 02-21-2025.

Forecast target price for 02-21-2025: $37.09.
Positive dynamics for GlaxoSmithKline shares will prevail with possible volatility of 0.825%.
Pessimistic target level: 36.99
Optimistic target level: 37.30

GSK (GSK) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Mar. 36.22 35.96 36.47 1.40
Apr. 36.46 36.24 36.87 1.69
May. 36.50 35.62 37.26 4.41
Jun. 35.73 34.97 36.08 3.09
Jul. 35.02 34.31 35.28 2.77
Aug. 35.27 34.89 35.94 2.92
Sep. 34.97 34.37 35.38 2.85
Oct. 35.25 34.44 36.04 4.46
Nov. 35.48 35.16 36.29 3.11
Dec. 34.91 34.40 35.35 2.70

GlaxoSmithKline forecast for this year


GlaxoSmithKline Stock Prediction for Mar 2025

An downtrend is forecast for this month with an optimal target price of $36.2238. Pessimistic: $35.96. Optimistic: $36.47


GlaxoSmithKline Stock Prediction for Apr 2025

An uptrend is forecast for this month with an optimal target price of $36.4629. Pessimistic: $36.24. Optimistic: $36.87


GlaxoSmithKline Stock Prediction for May 2025

An uptrend is forecast for this month with an optimal target price of $36.4957. Pessimistic: $35.62. Optimistic: $37.26


GlaxoSmithKline Stock Prediction for Jun 2025

An downtrend is forecast for this month with an optimal target price of $35.7293. Pessimistic: $34.97. Optimistic: $36.08


GlaxoSmithKline Stock Prediction for Jul 2025

An downtrend is forecast for this month with an optimal target price of $35.0218. Pessimistic: $34.31. Optimistic: $35.28


GlaxoSmithKline Stock Prediction for Aug 2025

An uptrend is forecast for this month with an optimal target price of $35.274. Pessimistic: $34.89. Optimistic: $35.94


GlaxoSmithKline Stock Prediction for Sep 2025

An downtrend is forecast for this month with an optimal target price of $34.9671. Pessimistic: $34.37. Optimistic: $35.38


GlaxoSmithKline Stock Prediction for Oct 2025

An uptrend is forecast for this month with an optimal target price of $35.2504. Pessimistic: $34.44. Optimistic: $36.04


GlaxoSmithKline Stock Prediction for Nov 2025

An uptrend is forecast for this month with an optimal target price of $35.483. Pessimistic: $35.16. Optimistic: $36.29


GlaxoSmithKline Stock Prediction for Dec 2025

An downtrend is forecast for this month with an optimal target price of $34.9082. Pessimistic: $34.40. Optimistic: $35.35



GlaxoSmithKline (GSK) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 34.56 34.20 35.00 2.28
Feb 34.31 33.84 34.67 2.40
Mar 33.99 33.79 34.67 2.53
Apr 34.91 34.64 35.60 2.71
May 34.65 34.08 34.86 2.24
Jun 34.43 33.77 34.90 3.23
Jul 34.12 33.77 34.87 3.14
Aug 34.58 34.29 34.83 1.55
Sep 35.03 34.55 35.26 2.03
Oct 34.38 33.70 34.81 3.20
Nov 34.11 33.72 34.71 2.86
Dec 34.03 33.73 34.29 1.64

GlaxoSmithKline (GSK) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 34.02 33.61 34.27 1.94
Feb 34.16 33.55 34.75 3.48
Mar 34.49 33.96 35.17 3.44
Apr 34.08 33.62 34.30 1.97
May 34.26 33.99 35.08 3.11
Jun 33.96 33.61 34.76 3.28
Jul 34.31 33.96 34.74 2.25
Aug 33.28 33.00 33.78 2.31
Sep 32.61 32.14 33.27 3.41
Oct 32.77 32.22 33.17 2.85
Nov 33.53 32.94 33.88 2.79
Dec 34.22 33.92 34.72 2.31

GlaxoSmithKline information and performance

GlaxoSmithKline Address

980 GREAT WEST ROAD, BRENTFORD MIDDLESEX, GB

Market Capitalization: 75 500 913 000 $

Market capitalization of the GlaxoSmithKline plc is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GSK shares in the company outstanding by the market price of one share.

EBITDA: 9 257 000 000 $

EBITDA of GlaxoSmithKline is earnings before interest, income tax and depreciation of assets.

PE Ratio: 23.25

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 0.798

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0447

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 1.55

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.282
Quarterly Revenue Growth YOY: -0.017
Trailing PE: 23.25

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 8.38

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 2.342

Enterprise Value (EV) /Revenue

EV To EBITDA: 10.3

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 2040820000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

GlaxoSmithKline (GSK) stock dividend

GlaxoSmithKline last paid dividends on 11/15/2024. The next scheduled payment will be on 01/09/2025. The amount of dividends is $0 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.

FAQ (Frequently Asked Questions about GlaxoSmithKline Stock)

Should I Buy GlaxoSmithKline Shares in 2025 year?

The maximum forecasted share price for next year is $35.03, Это на 1.52$ меньше чем текущая цена акций. Инвестируя сегодня в акции GlaxoSmithKline на срок 1 год вы получите убыток в размере 4.16%. With an investment horizon of up to two years, the target share price is 34.49$. Убыток: 5.64% (-2.06$ на каждую акцию).

Does GlaxoSmithKline pay dividends?

No, it does not

Which economic sector do GlaxoSmithKline's shares belong to?

GlaxoSmithKline's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as GlaxoSmithKline's shares?

You can view all the stocks that are part of the same sector as GlaxoSmithKline's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.